These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15161574)

  • 1. Translating the results of phase III randomized cancer trials into the language of physician obligation to patients.
    Markman M
    Curr Oncol Rep; 2004 Jul; 6(4):243-4. PubMed ID: 15161574
    [No Abstract]   [Full Text] [Related]  

  • 2. Communication with the patient in clinical research.
    Zwitter M
    Ann N Y Acad Sci; 1997 Feb; 809():83-96. PubMed ID: 9103560
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials.
    Brown RF; Butow PN; Butt DG; Moore AR; Tattersall MH
    Soc Sci Med; 2004 Jan; 58(2):379-90. PubMed ID: 14604623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician-patient communication in phase I cancer trials.
    Nitschke R
    J Clin Oncol; 2004 Feb; 22(3):571-2; author reply 572-3. PubMed ID: 14752086
    [No Abstract]   [Full Text] [Related]  

  • 5. Locally advanced non-small cell lung cancer: do we know the questions? A survey of randomized trials from 1966-1993.
    Brundage MD; Mackillop WJ
    J Clin Epidemiol; 1996 Feb; 49(2):183-92. PubMed ID: 8606319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Holding on and letting go: ethical issues regarding the care of children with cancer.
    Goldberg A; Frader J
    Cancer Treat Res; 2008; 140():173-94. PubMed ID: 18283776
    [No Abstract]   [Full Text] [Related]  

  • 7. Negotiating a request for nondisclosure.
    Cochella SE; Pedersen DM
    Am Fam Physician; 2003 Jan; 67(1):209-11. PubMed ID: 12537182
    [No Abstract]   [Full Text] [Related]  

  • 8. Transparency and self-censorship in shared decision-making.
    Brody H
    Am J Bioeth; 2007 Jul; 7(7):44-6. PubMed ID: 17654386
    [No Abstract]   [Full Text] [Related]  

  • 9. The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial.
    Siegle A; Villalobos M; Bossert J; Krug K; Hagelskamp L; Krisam J; Handtke V; Deis N; Jünger J; Wensing M; Thomas M
    Trials; 2018 Aug; 19(1):438. PubMed ID: 30107809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical ethics and therapeutic progress: example of lung cancer. Help, Hippocrates!].
    Lebeau B
    Rev Mal Respir; 1999 Nov; 16(5):863-5. PubMed ID: 10612163
    [No Abstract]   [Full Text] [Related]  

  • 11. "I want to live, until I don't want to live anymore": involving children with life-threatening and life-shortening illnesses in decision making about care and treatment.
    Bluebond-Langner M; Belasco JB; DeMesquita Wander M
    Nurs Clin North Am; 2010 Sep; 45(3):329-43. PubMed ID: 20804881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigating difficult conversations.
    Johnston FM; Beckman M
    J Surg Oncol; 2019 Jul; 120(1):23-29. PubMed ID: 31001875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What physicians see and don't see--moral perception of the physician-patient relations].
    Heidenreich KS
    Tidsskr Nor Laegeforen; 2004 Feb; 124(3):369-72. PubMed ID: 14969241
    [No Abstract]   [Full Text] [Related]  

  • 14. How should careproviders respond when the medical system leaves a patient short?
    Howe EG
    J Clin Ethics; 2007; 18(3):195-205. PubMed ID: 18051936
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute stroke trials: the elephant in the room.
    Goyal M
    Neuroradiology; 2013 Aug; 55(8):929-931. PubMed ID: 23644541
    [No Abstract]   [Full Text] [Related]  

  • 16. Truth or lie--some ethical dilemmas in the communication of a severe diagnosis.
    Gramma R; Parvu A; Enache A; Roman G; Ioan B
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):172-82. PubMed ID: 24505911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in lung cancer: truth, justice, and the American way.
    Feins RH
    Ann Thorac Surg; 2000 Oct; 70(4):1139-41. PubMed ID: 11081857
    [No Abstract]   [Full Text] [Related]  

  • 18. Pravastatin has no advantage in small-cell lung cancer.
    Brower V
    Lancet Oncol; 2017 Apr; 18(4):e204. PubMed ID: 28285843
    [No Abstract]   [Full Text] [Related]  

  • 19. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.
    Meropol NJ; Weinfurt KP; Burnett CB; Balshem A; Benson AB; Castel L; Corbett S; Diefenbach M; Gaskin D; Li Y; Manne S; Marshall J; Rowland JH; Slater E; Sulmasy DP; Van Echo D; Washington S; Schulman KA
    J Clin Oncol; 2003 Jul; 21(13):2589-96. PubMed ID: 12829680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honoring a Patient: From Suspicion to Diagnosis.
    Rosner S; Insetta ER
    Am J Med; 2018 Oct; 131(10):1263-1264. PubMed ID: 29621476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.